Evidence map›Paper›PMID 30761981›Full record

ArticleThe American journal of tropical medicine and hygiene2019

Differences in the Clinical and Laboratory Features of Imported Onchocerciasis in Endemic Individuals and Temporary Residents.

Adrienne J Showler, Joseph Kubofcik, Alessandra Ricciardi, Thomas B Nutman

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00001230 (Host Response to Infection and Treatment in the Filarial Diseases of Humans), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00001230 recruitingnot on this map

Host Response to Infection and Treatment in the Filarial Diseases of Humans

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran1991Enrolled500ConditionsFilariasis, Helminthiasis, Parasitic Infection, MansonelliasisArmsDiethylcarbamazine
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Adrienne J ShowlerDivision of Infectious Disease, Georgetown University, Washington, District of Columbia.
Joseph KubofcikLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Alessandra RicciardiLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Thomas B NutmanLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
National Institutes of Health · USNational Institute of Allergy and Infectious Diseases · US

Funding

Clinical And Therapeutic Studies Of Human Filariasis and Related DiseasesZIAAI000439 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2025
$14.8M
6 · The paper itself

Abstract

Many parasitic infections have different presenting features in endemic individuals (ENDs) and immunologically naive temporary residents (TRs). Temporary residents with loiasis often display acute symptoms and hypereosinophilia, in contrast to a parasite-induced subclinical state in chronically infected ENDs. Few studies have examined differences in ENDs and TRs infected with the related filarial parasite

Indexed as

Emigration and ImmigrationAcute DiseaseAdultAnimalsAntibodies, HelminthAsymptomatic InfectionsChronic DiseaseClinical Laboratory TechniquesEndemic DiseasesEye DiseasesFemaleHumansImmunoglobulin GMaleMiddle AgedOnchocerca volvulusAntibodies, HelminthImmunoglobulin G

Identifiers

PMID30761981
PMCPMC6493925
OpenAlexW2913932675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.